Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Inclusion body myopathy associated with Paget’s disease and frontotemporal dementia (IBMPFD) is caused by mutations in the valosin containing protein (VCP) gene. The disease is associated with progressive proximal muscle weakness, inclusions and vacuoles in muscle fibers, malfunction in the bone remodeling process resulting in Paget disease, and premature frontotemporal dementia. VCP is involved in several cellular processes related to the endoplasmic reticulum associated degradation of proteins. To understand the pathological mechanisms underlying the myopathy in IBMPFD, we have studied the cellular consequences of VCP mutations in human primary myoblasts. Our results revealed that patients’ myoblasts accumulate large vacuoles. Lysosomal membrane proteins Lamp1 and Lamp2 show increased molecular weights in patients’ myoblasts due to differential N-glycosylation. Additionally, mutant myoblasts show increased autophagy when cultured in the absence of nutrients, as well as defective cell fusion and increased apoptosis. Our results elucidate that VCP mutations result in disturbances in several cellular processes, which will help us in the understanding of the pathological mechanisms resulting in muscle weakness and other features of VCP associated disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Watts, G. D. J., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P., & Kimonis, V. E. (2004) · Nature Genetics · doi:10.1038/ng1332 · Cited by 1,391 · cited 4×
“Premature frontotemporal dementia (FTD) [4] seen in the mid 50s, is characterized by B.V. diatrics, Division of Genetics al Center, 101 The City Drive fax: +1 714 456 5330. dysnomia, dyscalculia, auditory comprehension deficits for even one-step commands, alexia, agraphia, and later stages by inability to speak.”
BackgroundInfluentialSelf-citationPrimary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., et al. (2000) · Nature · doi:10.1038/35022604 · Cited by 959 · cited 1×
“This disease is caused by mutations in the Lamp2 gene that encodes a lysosomal membrane protein [28].”
BackgroundTargeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality
Müller, J. M. M., Deinhardt, K., Rosewell, I., Warren, G., & Shima, D. T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.206 · Cited by 133 · cited 2×
“The generation of a knock-out mouse model having only one functional VCP-gene also favors this hypothesis, since heterozygous mice having one wild-type allele and one deleted allele are indistinguishable from their wild-type littermates [23].”
BackgroundRoles of VCP in human neurodegenerative disorders
Kakizuka, A. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360105 · Cited by 64 · cited 2×
“This hypothesis is further supported by earlier studies showing normal hexamer formation and normal to elevated ATPase activities for the mutant VCP protein [16,17].”
Background
Cited by
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
Lagier-Tourenne, C., Polymenidou, M., & Cleveland, D. W. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq137 · Cited by 1,021
Tresse, E., Salomons, F. A., Vesa, J., Bott, L. C., Kimonis, V., Yao, T.-P., Dantuma, N. P., & Taylor, J. P. (2010) · Autophagy · doi:10.4161/auto.6.2.11014 · Cited by 437
Self-citationRea, S. L., Walsh, J. P., Layfield, R., Ratajczak, T., & Xu, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1034 · Cited by 123
Castets, P., Frank, S., Sinnreich, M., & Rüegg, M. A. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-160153 · Cited by 49
“Moreover, several reports suggest that VCP plays a role in endosome and autophagic vesicle trafficking: Autophagosomes accumulate in muscle from IBMPFD patients and VCP-deficient mice, as well as in primary human myoblasts [229, 234–237].”
BackgroundExercise Training Reverses Skeletal Muscle Atrophy in an Experimental Model of VCP Disease
Nalbandian, A., Nguyen, C., Katheria, V., Llewellyn, K. J., Badadani, M., Caiozzo, V., & Kimonis, V. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076187 · Cited by 30
“Previous studies in patient myoblasts have implicated impaired autophagy in the pathogenesis of VCP disease [39,40].”
BackgroundSelf-citation
Metadata
- Authors
- Vesa, J., Su, H., Watts, G. D., Krause, S., Walter, M. C., Martin, B., Smith, C., Wallace, D. C., & Kimonis, V. E.
- Venue
- Neuromuscular Disorders
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 19
- Issue
- 11
- Pages
- 766-772
- ISSN
- 0960-8966 (ISSN-L)
- OpenAlex
- W2169201164
- Cited by
- 61
- References
- 4
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. https://app.cochat.ai/papers/10.1016/j.nmd.2009.08.003
- The paper
- Vesa, J., Su, H., Watts, G. D., Krause, S., Walter, M. C., Martin, B., Smith, C., Wallace, D. C., & Kimonis, V. E. (2009). Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2009.08.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.